Clinical Trial Update: Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women [NA]

View source ↗

Summary

Clinical trial investigating PAMG-1 to diagnose premature rupture of membranes in pregnant women; study is terminated with results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Preterm Labor

Snippet

Sponsor: Mark Santillan | Conditions: Preterm Labor, Preterm Birth | NA | Status: TERMINATED | Results posted: 2019-10-03